396 related articles for article (PubMed ID: 20230542)
1. Autosomal dominant polycystic kidney disease: risk factor for nonmelanoma skin cancer following kidney transplantation.
Bretagnol A; Halimi JM; Roland M; Barbet C; Machet L; Al Najjar A; Marlière JF; Badin J; Nivet H; Lebranchu Y; Büchler M
Transpl Int; 2010 Sep; 23(9):878-86. PubMed ID: 20230542
[TBL] [Abstract][Full Text] [Related]
2. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
[TBL] [Abstract][Full Text] [Related]
3. Cancer incidence and survival in kidney transplant patients.
Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P
Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153
[TBL] [Abstract][Full Text] [Related]
4. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
[TBL] [Abstract][Full Text] [Related]
5. Non-melanoma skin cancer incidence and risk factors after kidney transplantation: a Canadian experience.
Comeau S; Jensen L; Cockfield SM; Sapijaszko M; Gourishankar S
Transplantation; 2008 Aug; 86(4):535-41. PubMed ID: 18724222
[TBL] [Abstract][Full Text] [Related]
6. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
7. [Renal transplantation in patients with autosomal dominant polycystic kidney disease: pre-transplantation evaluation and follow-up].
Bretagnol A; Büchler M; Boutin JM; Nivet H; Lebranchu Y; Chauveau D
Nephrol Ther; 2007 Dec; 3(7):449-55. PubMed ID: 18047999
[TBL] [Abstract][Full Text] [Related]
8. Autosomal-dominant polycystic kidney disease and kidney transplantation: experience of a single center.
Gonçalves S; Guerra J; Santana A; Abreu F; Mil-Homens C; Gomes da Costa A
Transplant Proc; 2009 Apr; 41(3):887-90. PubMed ID: 19376380
[TBL] [Abstract][Full Text] [Related]
9. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
[TBL] [Abstract][Full Text] [Related]
10. Favorable graft survival in renal transplant recipients with polycystic kidney disease.
Johnston O; O'Kelly P; Donohue J; Walshe JJ; Little DM; Hickey D; Conlon PJ
Ren Fail; 2005; 27(3):309-14. PubMed ID: 15957548
[TBL] [Abstract][Full Text] [Related]
11. Skin surveillance of a U.K. paediatric transplant population.
Thomson MA; Suggett NR; Nightingale PG; Milford DV; Baumann U; Kelly DA; Moss C; Hill VA
Br J Dermatol; 2007 Jan; 156(1):45-50. PubMed ID: 17199565
[TBL] [Abstract][Full Text] [Related]
12. New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study.
Ruderman I; Masterson R; Yates C; Gorelik A; Cohney SJ; Walker RG
Nephrology (Carlton); 2012 Jan; 17(1):89-96. PubMed ID: 21854501
[TBL] [Abstract][Full Text] [Related]
13. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
Herrero JI; España A; Quiroga J; Sangro B; Pardo F; Alvárez-Cienfuegos J; Prieto J
Liver Transpl; 2005 Sep; 11(9):1100-6. PubMed ID: 16123952
[TBL] [Abstract][Full Text] [Related]
14. HLA-B27 is a potential risk factor for posttransplantation diabetes mellitus in autosomal dominant polycystic kidney disease patients.
Pietrzak-Nowacka M; Safranow K; Nowosiad M; Dębska-Ślizień A; Dziewanowski K; Głyda M; Jankowska M; Rutkowski B; Ciechanowski K
Transplant Proc; 2010 Nov; 42(9):3465-70. PubMed ID: 21094798
[TBL] [Abstract][Full Text] [Related]
15. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.
Carroll RP; Ramsay HM; Fryer AA; Hawley CM; Nicol DL; Harden PN
Am J Kidney Dis; 2003 Mar; 41(3):676-83. PubMed ID: 12612993
[TBL] [Abstract][Full Text] [Related]
16. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
Bernat García J; Morales Suárez-Varela M; Vilata JJ; Marquina A; Pallardó L; Crespo J
Acta Derm Venereol; 2013 Jul; 93(4):422-7. PubMed ID: 23303600
[TBL] [Abstract][Full Text] [Related]
18. Excess risk of cancer in renal transplant patients.
Kessler M; Jay N; Molle R; Guillemin F
Transpl Int; 2006 Nov; 19(11):908-14. PubMed ID: 17018126
[TBL] [Abstract][Full Text] [Related]
19. Skin cancer in kidney transplant recipients affected with autosomal dominant polycystic kidney disease.
Jankowska M; Dębska-Ślizień A; Imko-Walczuk B; Piesiaków ML; Lizakowski S; Czarnacka K; Rutkowski B
Clin Transplant; 2016 Apr; 30(4):339-43. PubMed ID: 26916353
[No Abstract] [Full Text] [Related]
20. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
